Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
作者信息
Birkeland S A, Svendsen V, Rohr N, Hansen B L, Elbirk A, Foged N, Køhler F
机构信息
Department of Nephrology, University Hospital, Odense, Denmark.
出版信息
Transplant Proc. 1988 Jun;20(3):451-4.
PMID:3289183
Abstract
摘要
相似文献
1
Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Transplant Proc. 1988 Jun;20(3):451-4.
2
Monitoring immunosuppression following renal transplantation.
Diagn Immunol. 1983;1(3):174-8.
3
Monoclonal antibodies for kidney allograft rejection.
Med Lett Drugs Ther. 1986 Oct 10;28(724):97-8.
4
[Treatment of refractory acute rejection after renal transplantation with lymphogloline].
Zhonghua Wai Ke Za Zhi. 1994 Jun;32(6):348-50.
5
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Prog Clin Biol Res. 1986;224:239-49.
6
Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Transplant Proc. 1987 Apr;19(2 Suppl 1):28-31.
7
Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
J Clin Immunol. 1982 Jul;2(3 Suppl):142S-147S.
8
Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
J Heart Transplant. 1989 May-Jun;8(3):191-3.
9
Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
Transplant Proc. 1994 Feb;26(1):273-4.
10
Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Transplant Proc. 1996 Jun;28(3):1973-5.
Zotero 插件